Bispecific Antibodies Made Simple! Learn about bispecific antibodies, a cutting-edge class of drugs in myeloma treatment, designed to harness the patient's immune system to combat the disease effectively. In this video, we delve into the fundamentals of bispecific antibodies and their significant impact on myeloma treatment.
This episode of the Myeloma Made Simple Series is supported by Johnson and Johnson.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF | Donate Now! fundraise.myeloma.org/give/52...
Category
Nonprofits & Activism
License
Standard KZitem License
In most cases, captions are autogenerated by KZitem.
Негізгі бет Myeloma Made Simple: Bispecific Antibodies Made Simple | Bispecific Antibodies for Myeloma Treatment
Пікірлер: 4